Literature DB >> 27148679

An emerging, recognizable facial phenotype in association with mutations in GLI-similar 3 (GLIS3).

Paul Dimitri1, Elisa De Franco2, Abdelhadi M Habeb3, Fatih Gurbuz4, Khairya Moussa5, Doris Taha6, Jerry K H Wales7, Jacob Hogue8, Anne Slavotinek9, Ambika Shetty10, Meena Balasubramanian11.   

Abstract

Neonatal diabetes and hypothyroidism (NDH) syndrome was first described in 2003 in a consanguineous Saudi Arabian family where two out of four siblings were reported to have presented with proportionate IUGR, neonatal non-autoimmune diabetes mellitus, severe congenital hypothyroidism, cholestasis, congenital glaucoma, and polycystic kidneys. Liver disease progressed to hepatic fibrosis. The renal disease was characterized by enlarged kidneys and multiple small cysts with deficient cortico-medullary junction differentiation and normal kidney function. There was minor facial dysmorphism (depressed nasal bridge, large anterior fontanelle, long philtrum) reported but no facial photographs were published. Mutations in the transcription factor GLI-similar 3 (GLIS3) gene in the original family and two other families were subsequently reported in 2006. All affected individuals had neonatal diabetes, congenital hypothyroidism but glaucoma and liver and kidney involvement were less consistent features. Detailed descriptions of the facial dysmorphism have not been reported previously. In this report, we describe the common facial dysmorphism consisting of bilateral low-set ears, depressed nasal bridge with overhanging columella, elongated, upslanted palpebral fissures, persistent long philtrum with a thin vermilion border of the upper lip in a cohort of seven patients with GLIS3 mutations and report the emergence of a distinct, probably recognizable facial gestalt in this group which evolves with age.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  GLIS3; facial dysmorphism; hypothyroidism; neonatal diabetes; phenotype

Mesh:

Substances:

Year:  2016        PMID: 27148679     DOI: 10.1002/ajmg.a.37680

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  8 in total

Review 1.  Congenital forms of diabetes: the beta-cell and beyond.

Authors:  Lisa R Letourneau; Siri Atma W Greeley
Journal:  Curr Opin Genet Dev       Date:  2018-02-16       Impact factor: 5.578

Review 2.  Transcription factor GLIS3: Critical roles in thyroid hormone biosynthesis, hypothyroidism, pancreatic beta cells and diabetes.

Authors:  David W Scoville; Hong Soon Kang; Anton M Jetten
Journal:  Pharmacol Ther       Date:  2020-07-18       Impact factor: 12.310

Review 3.  GLIS1-3 transcription factors: critical roles in the regulation of multiple physiological processes and diseases.

Authors:  Anton M Jetten
Journal:  Cell Mol Life Sci       Date:  2018-05-19       Impact factor: 9.261

Review 4.  Congenital Diabetes: Comprehensive Genetic Testing Allows for Improved Diagnosis and Treatment of Diabetes and Other Associated Features.

Authors:  Lisa R Letourneau; Siri Atma W Greeley
Journal:  Curr Diab Rep       Date:  2018-06-13       Impact factor: 4.810

5.  Genes uniquely expressed in human growth plate chondrocytes uncover a distinct regulatory network.

Authors:  Bing Li; Karthika Balasubramanian; Deborah Krakow; Daniel H Cohn
Journal:  BMC Genomics       Date:  2017-12-20       Impact factor: 3.969

6.  Case Report: Extended Clinical Spectrum of the Neonatal Diabetes With Congenital Hypothyroidism Syndrome.

Authors:  Vera Splittstoesser; Heike Vollbach; Michaela Plamper; Werner Garbe; Elisa De Franco; Jayne A L Houghton; Gesche Dueker; Rainer Ganschow; Bettina Gohlke; Felix Schreiner
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-16       Impact factor: 5.555

7.  Case Report: Neonatal Diabetes Mellitus Caused by a Novel GLIS3 Mutation in Twins.

Authors:  Shira London; Elisa De Franco; Ghadir Elias-Assad; Marie Noufi Barhoum; Clari Felszer; Marina Paniakov; Scott A Weiner; Yardena Tenenbaum-Rakover
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-18       Impact factor: 5.555

Review 8.  GLIS3: A Critical Transcription Factor in Islet β-Cell Generation.

Authors:  David W Scoville; Anton M Jetten
Journal:  Cells       Date:  2021-12-09       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.